Company intelligence / Profile preview
Bioplus Life Sciences
Bangalore, Karnataka, Indiabioplus.in ↗
- Ownership
- Private
- Employees
- ~750
- Development stage
- Preclinical
01
Overview
Two lead programs are Phase III ready for large unmet needs. Notable recent clinical data presented for pediatric myopia program "7-MX" showing high efficacy in children. EFSA approval secured for algal DHA use in infant formula.[2]
- Therapeutic areas
- GastroenterologyCardiovascularOphthalmologyWomen's Health
- Modalities
- Small molecules[1][4]Nutraceuticals/functional ingredients[3][4][9]Microbial fermentation products[4][5]Peptides & proteins[1]
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Focused on building global partnerships regionally/globally to optimize market access; specifics not disclosed but active outlicensing of generics to EU/ROW partners noted.[1][4][5]
Beyond the preview
Go deeper on Bioplus Life Sciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bioplus Life Sciences.